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Summary Formation of metastasis is a multistep process involving attachment to the basement membrane, local proteolysis and migration
into surrounding tissues, lymph or bloodstream. In the present study, we have analysed the correlation between in vitro invasion and presence
of the epidermal growth factor receptor (EGFR) in a panel of 21 small-cell lung cancer (SCLC) cell lines. We have previously reported that ten
of these cell lines expressed EGFR protein detected by radioreceptor and affinity labelling assays. In 11 small-cell lung cancer (SCLC) cell
lines, EGFR mRNA was detected by Northem blot analysis. In vitro invasion in a Boyden chamber assay was found in all EGFR-positive cell
lines, whereas no invasion was detected in the EGFR-negative cell lines. Quantification of the in vitro invasion in 12 selected SCLC cell lines
demonstrated that, in the EGFR-positive cell lines, between 5% and 16% of the cells added to the upper chamber were able to traverse the
Matriel membrane. Expression of several matrix metalloproteases (MMP), of tissue inhibitor of MMP (TIMP) and of cathepsin B was
evaluated by immunoprecipitation, Westem blot analysis and reverse transcriptase polymerase chain reaction (RT-PCR). However, in vitro
invasive SCLC cell lines could not be distinguished from non-invasive cell lines based on the expression pattern of these molecules. In six
SCLC cell lines, in vitro invasion was also determined in the presence of the EGFR-neutralizing monoclonal antibody mAb528. The addition
of this antibody resulted in a significant reduction of the in vitro invasion in three selected EGFR-positive cell lines. Our results show that only
EGFR-positive SCLC cell lines had the in vitro invasive phenotype, and it is therefore suggested that the EGFR might play an important role
for the invasion potential of SCLC cell lines.
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Growth factors have been suggested to play a significant role in
the processes leading up to the formation ofmetastasis. In a human
gastric adenocarcinoma cell line. hepatocyte growth factor (HGF)
and transforming growth factor P (TGFf) have been shown to
stimulate in vitro invasion in the Boyden chamber assay
(Shibamoto et al. 1992) and. in the intestinal epithelial cell line
TEC-6. fibroblast growth factor (FGF) and keratinocyte growth
factor (KGF) stimulated cell migration in an in vitro wound model
(Dignass et al. 1994). The v-erbA oncogene coding for a truncated
thyroid hormone receptor has been shown to cooperate with
platelet-derived growth factor (PDGF) to increase in vitro invasion
(Lianos et al. 1996). Over the last decade. several reports have
shown a correlation between the presence ofthe epidermal growth
factor receptor EGFR and invasive tumours. higher stages or
progressive disease. In bladder cancer. it was found that signifi-
cantly more invasive tumours than superficial tumours stained
positive for EGFR. 87.5% and 29.2% respectively (Neal et al.
1985). and in non-small-cell lung cancer (NSCLC) stage III
tumours stained more strongly than stage I and II (Veale et al.
1987). In a study of 156 gastric carcinomas. a significant correla-
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tion was found between EGFR and depth of local invasion (Yasui
et al. 1988). Furthermore. 34%7 of advanced carcinomas were
EGFR positive compared with only 4% ofearly-stage carcinomas.
In oesophageal squamous cell carcinoma, it has been shown that
lymph node metastasis was more frequent and that patients had a
worse overall prognosis ifthe primary tumour was EGFR positive
(Yano et al. 1991). In contrast no correlation between EGFR levels
and Dukes' classification of colon tumours has been established
(Jasonni et al. 1995). In cell lines. an increased invasion potential
has been associated with the presence of EGFR (Yoshida et al.
1990: Lund-Johansen et al. 1992: de Wit et al. 1992: Holting et al.
1994). In one study. six human melanoma cell lines were exam-
ined for their ability to give rise to spontaneous lung metastasis in
nude mice. Cell lines with a high metastatic potential also had high
levels ofEGFR expression. whereas those cell lines with low or no
metastatic potential had low or undetectable EGFR expression (de
Wit et al. 1992). Overall, these results indicate that EGFR has a
role in the malignant phenotype. Attachment to the basement
membrane and cell motility are some of the first steps involxed in
tumour cell invasion (Fidler and Nicolson. 1987) and EGF has also
been demonstrated to play a role in this initial phase. Attachment
of cells to fibronectin has been shown to be mediated by the
fibronectin receptor: furthermore. this attachment was enhanced
by EGF in a rabbit corneal epithelial cell (Nishida et al. 1992).
After the initial attachment. malignant cells have to degrade the
basement membrane before they can disseminate. The ability to
degrade various components of the basement membrane has been
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FIgure 1 In vitro invasion of SCLC cell Ones using the Boyden chamber assay (A). Cells (2 x 105) were seeded in the upWer chamber and incubated for 9 h
before Fte cells on the underside were fixed and stained as described in Materials and methods. In (B) the EGFR-negative SCLC cell line NCIH69; no cells
have traversed the Matrigel membrane. The arrow indicates the 12jim pore in the PVP-fiter. In (C), the EGFR-positive SCLC cell line GLC2 (graded as +). In
vitro inasion of the positve control cell line (breast cancer cel line MDA-MB-231) is seen in (D). AN experiments were performed in duplicate and at least three
times with similar results
ascribed to proteases (Tryggvarson et al, 1987). One of these
systems involves the serine protease plasmin, which is derived
from plasminogen mediated by urokinase-type plasminogen acti-
vator (uPA) or tissue-type plasminogen activator (tPA) (Liotta et
al. 1991; Wun et al, 1982). Several reports have indicated the role
ofuPA in the invasive phenotype in both cell lines and in primary
tumours. where it is predominantly located at the leading edges of
the tumour (Markus et al, 1983; Skriver et al, 1984; Kohga et al,
1985; Sappino et al, 1987: Hollas et al, 1991; Hoosein et al, 1991;
Ossowski et al, 1991; Reith and Rucklidge, 1992). Other reports
have shown that MMPs are also involved in the invasive pheno-
type by degrading various components ofthe basement membrane
(McDonnell and Matrisian, 1990; McDonnell et al, 1991:
Salamonsen et al, 1991: Marcotte et al, 1992; Okada et al, 1992;
Sreenath et al, 1992; Liabakk et al, 1996). The knowledge of the
complexity of this protease system has now been increased as
TIMPs have been found.
The human epidermoid carcinoma cell line HEp-3 loses its
invasive phenotype after prolonged in vitro culturing and a
concomitant increase in TIMP-2 mRNA (Testa, 1992). These
results indicate that the balance between these basement
membrane-degrading proteases and their inhibitors could be offset
and alteration in one ofthese could lead to the invasive phenotype.
In order to elucidate the role of the EGFR in SCLC cell lines,
we examined the in vitro invasion profile in ourpanel of21 SCLC
cell lines and correlated these results to EGFR expression.
Furthermore, the effect on in vitro invasion afterthe addition of an
EGFR neutralizing monoclonal antibody was investigated. Our
findings lend support to the hypothesis that the EGFR plays a
critical role in the process ofin vitro invasion ofSCLC cell lines.
MATERIALS AND METHODS
Cell lines
SCLC cell lines were cultured in 75-cm2 flasks at 370C, 5% carbon
dioxide and 80% humidity in medium containing 10% fetal calf
serum (FCS) (Flow Laboratories. Irvine. UK) without antibiotics.
Our panel of 21 SCLC cell lines from 17 patients was established
in five laboratories. The origin and establishment have been
described elsewhere (Pettengill et al. 1980: Carney et al. 1985; de
Leij et al, 1985; Engelholm et al. 1986. Bepler et al. 1987:
Berendsen et al, 1988). For invasion assays, cells in exponential
growth were harvested and single cell suspension was obtained by
mechanical disaggregation.
Reagents
All cell culture reagents were purchased from Gibco
Laboratories/Life Technologies (Roskilde. Denmark) and all
chemicals were purchased from Sigma Chemical (St Louis. MO,
USA). unless otherwise indicated- All reagents for electrophoresis
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were purchased from Bio-Rad (Copenhagen. Denmark). All
enhanced chemiluminescence (ECL)-related materials were
purchased from Amersham International (Little Chalfont. UK).
Mouse IgG, rabbit anti-mouse IgG and horseradish peroxidase-
conjugated streptavidin were purchased from Jackson
Collaborative (Westgrove, PA. USA). Matrigel was purchased
from Collaborative Research (MA. USA) and polycarbonate
membrane filters (PVP-free 13 mm in diameter with 12-jim pores)
from Poretics (Livermore. CA. USA). Diff-Quick stain was
purchased from American Scientific Products (McGaw Park, IL,
USA). Protein A-agarose was purchased from Pierce Europe (BA
Oud Beijerland, the Netherlands). Transwell filters were obtained
from Costar (Cambridge, MA, USA). Quick prep mRNA kit and
specific oligonucleotides were purchased from Pharmacia Biotech
(Uppsala, Sweden). cDNA synthesis kit was purchased from
Boehringer Mannheim (Mannheim. Germany). Thermoprime plus
was purchased from Advanced Biotechnology (Leatherhead, UK).
Anrbodis
Monoclonal antibody to human EGFR (mAb528). cathepsin-B.
THMP-2, MMP-l, MMP-2 and MMP-9 and the control antibody
tre-P were purchased from Oncogene Science (Cambridge, MA,
USA). All antibodies except mAbS28 were used to detect the
corresponding proteins in either immunoprecipitation studies
(TIMP-2 and MMP-9) or Western blot analysis (cathepsin-B,
MMP-I and MMP-2) as per the manufacturer's recommendations.
Semiquantfied in vitro invasion assay
The Boyden chamber in vitro invasion assay was performed as
described elsewhere (Albini et al, 1987). In brief, Matrigel was
diluted with ice-cold phosphate-buffered saline (154 mm sodium
chloride. 1.5 mm potassium dihydrogen phosphate, 2.7 mm
sodium hydrogen phosphate, 1 mm magnesium chloride and
).l mm calcium chloride, pH 7.2) (PBS), added to each filter and
left to polymerize and dry overnight. The polymerized and dried
Matrigel membranes were reconstituted with serum-free medium
for 10 min at room temperature (RT). The lower chamber was
filled with serum-free medium (200 l) before the chamber was
issembled. Cells (2 x 10-) were added to serum-free medium in
the upper chamber (Figure IA) and incubated under standard
conditions for 9 h. The filters were stained with Diff-Quick and
cells on the upper side of the filter scraped off before the filters
were photographed The semiquantified invasion was estimated by
!valuating the concentration of cells in the medium in the lower
chamber, the number of cells on the underside of the filter and
,elating this to concentration of cells in the upper chamber. We
praded the invasion based on this from negative 0 to +++.
Duantified in vitro invasion
Essentially the same procedure as above was used, however the
ncubation period was extended to 24 h and 12-mm Transwell
ilters were used with 12-im pores. The Matrigel membrane was
)repared by diluting 50 jg of Matrigel (in some studies 0 or
100 jg) in 250 jl of medium containing 10% FCS. For these in
iitro invasion assays, estimation of invasion was performed by
he 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
MTh) assay as described elsewhere (Vistica et al. 1991). MTT
was added to both sides of the filter. Crossover of insoluble dye
from the top to the lower compartment in the presence of the
Matrigel membrane was determined in parallel experiments by
adding MTT immediately after seeding the cells and subtracted
from the observed in vitro invasion. For each experiment. a stan-
dard curve of absorbance at 562 nm and cell number was gener-
ated. From this standard curve, cell number in each compartment
was established and per cent invasion was determined.
Secretion of proeoyc enzymes
Proteolytic activity of the SCLC cell lines was visualized by
zymograms (Heussen and Dowdle, 1980). Cells were seeded in
25-cm2 flasks in the usual culture medium. After 24 h. the medium
was changed to RPMI-1640 with 1% serum. and the cells were
cultured for 4 days without change of medium. The conditioned
medium was then examined for secreted proteases. One-millilitre
aliquots of the conditioned medium were dried and dissolved in
non-denaturing SDS-PAGE sample buffer, and the samples were
loaded without heating on a 7% acrylamide gel. The gel was
prepared with either 1 mg ml-' fcasein or gelatine. After elec-
trophoresis, the gels were washed for 2 x 30 min in 2.5% (v/v)
Triton X-100, to remove SDS and placed in substrate buffer
(50 mm Tris, 75 mM sodium chloride. 10 mm calcium chloride, 3
mM sodium azide, pH 7.5) and incubated at 370C for 24 h. The
zymograms were stained with 0.25% Coomassie brilliant blue R-
250. The gels weredestained until bands appearedclearagainst the
bluebackground. The gels were dried between two layers ofcello-
phane andphotographed.
Immunoprecipiion and Western blot analysis
All procedures were performed at 40C unless otherwise stated.
Confluent SCLC cells were washed four times in phosphate-
buffered saline-bovine serum albumin (PBS-BSA). lysed for I h
and cleared by centrifugation. After an overnight incubation with
antibodies directed against MMP-9 or TIMP-2 (1 jg ml-').
followed by a 2-h incubation with 2 jg rabbit anti-mouse IgG. the
lysate was incubated for 1 h with protein-A agarose. Bound anti-
gens were analysed on SDS-PAGE under reducing conditions and
electrophoretically transferred overnight at 30 V to a supported
0.2 jg PVDF membrane. The filters were blocked in T-TBS
(50 mM Tris-HCl pH 7.5, 150 mm sodium chloride. 0.05% Tween-
20) containing 5% bovine serum albumin (BSA). Filters were
washed three times inT-TBS, incubated at RT for45 min in T-TBS
with primary antibodies and washed. The blots were incubated
with biotinylated rabbit anti-mouse IgG for 1 h and washed before
being incubated for 1 h with streptavidin-conjugated horseradish
peroxidase. Finally, the filters were washed six times in T-TBS
over 3 h. ECL solution was added to the filter for 1 min before
autoradiography was performed for S sec to 1 min. For Western
blots, an aliquot of the cell lysate was run directly on the SDS-
PAGE gel and proteins transferred and blotted using 1 jg ml'
antibodies directed against MMP-1.2 or cathepsin-B and detected
as described above.
Detetion of mRNA by RT-PCR
mRNA was isolated from exponentially growing SCLC cell lines
using Quick prep mRNA kit. cDNA was synthesized from
0.5 jg of mRNA using the cDNA synthesis kit. Polymerase chain
reaction (PCR) was performed using Thermoprime Plus and
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specific primers for each of the examined mRNAs. Specific
primers (in 5'-3' direction) for:
TIMP-1: TGTTGTTGCTGTGGCTGATAGC and
AGGTAGTGATGTGCAAGAGTCC.
TIMP-2: TTGATGCAGGCGAAGAACITTGG and
AAGGAAGTGGACTCTGGAAACG.
TIMP-3: TCATTC1T-lCTGGCATGGCACC and
ATCAAGTCCTGCTACTACCTGC.
MMP-2: CTTCGCCCCAGGCACTGGTG and
CCTCGCTCCCATGGGGTTCGGT.
MMP-3: TCACATTCAGCACTGGAAGACG and
TCTCAGGGTCTCCTACYITTGG.
MMP-9: GGTCCCCCCACTGCTGGCCCTTCTACGGCC
and GTCCTCAGGGCACTGGAGGATGTCATAGGT.
GAPDH: TGAAGGTCGGTGTGAACGGATFITGG and
ACGACATACTCAGCACCAGCATCAC
GAPDH was used as a positive and reaction control. All reac-
tions were subjected to 30cycles ofPCR amplification. Each cycle
consisted of 30 s ofdenaturation at 94CC. 1 min at primer-specific
annealing temperature (60'C for GAPDH: 640C for TIMP-1.
TIMP-2. TIMP-3 and MMP-3: 680C for MMP-2 and MMP-9) and
1 min ofprimer extension at 72CC. The PCR products were visual-
ized after electrophoresis on a 1% agarose gel containing ethidium
bromide. The appearance of specific bands (TIMP-1. 356 bp:
TIMP-2. 428 bp: TIMP-3. 456 bp: MMP-2. 1085 bp: MMP-3. 432
bp: MMP-9. 640 bp: GAPDH. 269 bp) was evaluated under ultra-
violet light and photographed.
Quantified in vitro invasion in the presence of EGFR
mAb
In separate studies. six SCLC cell lines. GLC3. GLC14. NCIH69.
DMS53. MAR24H and CPH54A. were used to evaluate in vitro
Table 1 Characteristics of SCLC cell lines
Cell line Growth morphology EGFR status Invasion (LM)
DMS53 M + ++
DMS79 F +
DMS92 M (+)a ++
DMS114 M + ++
DMS153 M + +
DMS273 M + ++
DMS406 M - 0
DMS456 M - 0
GLC2 M + +++
GLC3 F - 0
GLC14 F - 0
GLC16 F - 0
GLC19 F - 0
GLC26 F - 0
GLC28 F - 0
MAR24H- F + ++
MAR86M1 F - 0
NCIH69 F - 0
NCI417N F + ++
CPH54A M + +
CPH54B M + +
SCLC cell lines were cultured either as monolayer cultures (M) orfloating
aggregates (F). EGFR status was evaluated by Northern blot analyss,
chemical cross-linking and Scatchard analysis of the receptor-specific
binding data. -, EGFR-negative cell lines, +, EGFR-positive cell lines,
a,DMS92 was positive by Northern blot analysis but the EGFR could not be
detected by the other methods (Darnstrup et al, 1992). We have also
detected the EGFR in DMS92 by RT-PCR (data not shown). In vitro invasion
was determined under serum-free conditions by a semiquantified 9-h
incubation assay using Boyden chambers. Number of cells on the underside
of the filters and the medium in the lower chamber was evaluated by light
microscopy (LM). In vitro invasion was scored from negative (0) to positive
(i++i-). The breast cancer cell line MDA-MB-231 was run in each experiment
as a positive control (scored as +++) and in vitro invasion of SCLC cell lines
was scored in relationship to this cell line. All invasion experiments were
performed at least three times with similar results.
Table 2 EGFR expression, migration and in vitro invasion in relation to Matrigel concentration
Invasion (%) Invasion (%) Invasion (%)
Cell line EGFR (B.,) s.d. (50pg gel) s.d. (0 Ag gel) sAd. (100 Ag gel) s.d.
DMS53 8.2 0.6 11.6 2.8 21.6 7.7 1.9 0.9
DMS92 - 16.2 7.8 48.6 15.4 6.7 2.5
DMS114 5.2 0.5 5.0 1.4 22.9 3.4 2.0 0.9
DMS273 3.2 0.9 13.2 4.2 32.5 6.0 7.6 2.0
GLC2 28.3 1.9 8.3 2.1 50.6 11.5 3.6 1.8
GLC3 Neg 0.7 1.4 28.3 11.2 1.0 0.0
GLC14 Neg 1.8 0.4 26.6 1.0 0.2 0.3
GLC19 Neg 2.3 0.9 27.3 2.3 1.9 1.2
NCIH69 Neg 0.0 0.0 22.9 0.3 0.0 0.0
MAR24H 11.6 2.3 14.0 0.9 27.5 0.7 5.8 0.7
CPH54A 6.1 0.6 6.5 2.3 25.2 9.3 3.9 1.6
CPH54B 5.3 0.5 5.2 1.9 19.3 8.8 2.7 2.3
Panel A B C D
Maxirmal EGFR binding (Be) expressed as fmol mg-' protein was determined at least three times, the mean values with ± s.d. are given (Panel A). In vitro
invasion of eight EGFR-positive and four EGFR-negative SCLC cell lines was determined after a 24-h incubation under serum-containing conditions on
Transwell filters and quantified by te MTT assay as described in Materials and methods. The Transwell filters were coated with 50 pg Matrigel. Cell number on
both sides of the filters were established by the MTT assay (Panel B). For each experiment a standard curve was run and absorbance at 562 nm was used to
determine cell number. In other experiments, the Transwell filters were coated with 0 (Panel C) or 100 pg (Panel D) Matrigel. Values represent the means ± s.d.
of experiments performed in triplicate. Experiments were performed at least twice.
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Figure 2 Migration and invasion profile of DMS92 with 0, 50 and 100 9g
Matrigel. For this cell line, te in vitro invasion was performed six times by
two investigators. All 18 points are given to illustrate inter- and intra-
experimental variation. The box plot indicates the means, average and 5/95%
confidence intervals for all data points
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invasion in the presence of the EGFR neutralizing monoclonal
antibody mAb528. In these experiments. performed on Transwell
filters. 1 jg ml-' mAb528 was added to the Matrigel. the apical
and basal medium. Cells were cultured for 24 h in serum-free
medium before the experiment and added to the serum-free
medium containing 1 jg ml-' mAb528 at the beginning of the
experiment. Cells were incubated on the Transwell filters for 24 h.
An irrelevant mouse monoclonal antibody tre-P and mouse IgG
were used as controls.
Statistics
All experiments were performed in triplicate and values are given
as means ± s.d. For evaluation of differences. student t-test was
used. All experiments were performed at least twice.
RESULTS
Semiquantified in vitro invasion
We first examined all cell lines for in vitro invasion through a
Matrigel membrane in a 9-h Boyden chamber invasion assay. The
ability to traverse the Matrigel membrane was assessed by evalu-
ating the number ofcells on the filter together with the number of
cells in the lower chamber. and relating this to the number ofcells
in the upperchamber. This was performed to avoid underscoring in
vitro invasion of cells growing as floating aggregates. as these
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Figure 3 SCLC cell lines were cultured until confluence, at which point the medium was changed to RPMI-1640 including 1% FCS. After 4 days, te
conditioned medium was collected and concentrated by freeze-drying. The redissoed material was run on a 7% SDS-PAGE gel, cast with either 1 mg meIn >-
casein (A) or gelatin (B), and incubated for 24 h at 37-C, stained and destained until desired contrast, between clear bands and the blue background, was
obtained. Molecular weight markers (Bio-Rad) are indicated on the lefL Experiments were performed twice with similar results
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Table 3 Detection of proteolytc enzymes in SCLC cell lines
Immunoprecipitation Westen blo analys
Cell line EGFR MMP-9 TIMP-2 MMP-1 MMP-2 Cahepsin B
DMS53 + + + - - +
DMS579 + + + - - +
DMS92 + + + - - +
DMS114 + + + - - +
DMS153 + + + - - (+)
DMS273 + + + - - +
DMS406 - + + - - +
DMS456 - + + - - -
GLC2 + + + - - (+)
GLC3 - + + - - +
GLC14 - NT + - NT NT
GLC16 - + + - - (+)
GLC19 - + + - - +
GLC26 - + + - - -
GLC28 - + + - - -
MAR24H + + + - - -
MAR86M1 - + + - -
NCIF169 - + + - - +
NCI417N + + + - - -
CPH54A + + + - - +
CPH54B + + + - - +
SCLC cell lines were cultured until confluence before immunoprecipitabon
was performed using 1 pg monoclonal antibody directed against MMP-9 or
TIMP-2, and run on a 7.5% SDS page gel (MMP-9) or a 12.5-20% gradient
gel (TIMP-2). In Western blot analysis (MMP-1, MMP-2 and cathepsin B),
100 gg protein was run on a 7.5% SDS-PAGE gel. Antigens were detected as
described in Materials and methods. NT, Not tested. Experiments were
performed twice with similar results.
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Table 4 RT-PCR detection of MMP and TIMP expression of proteoc
enzymes in SCLC cell lines
MMP TIMP
Cell line 2 3 9 1 2 3
DMS53 - - + + + )
DMS79 - + + (+) + +
DMS92 - - + - + -
DMS114 - - + + + +
DMS153 - - + + + +
DMS273 - - + + + +
DMS406 - - + - + (+)
DMS456 - - + + + -
GLC2 - + + + + +
GLC3 - + + + + +
GLC14 - + + + + +
GLC16 - (+) + (+) + +
GLC19 - + + + + _
GLC26 - - (+) + + +
GLC28 - + + + +
MAR24H - - (+) + + +
MAR86M1 - + + + + +
NC1H69 - + ( + +
NC1417N - + + + + -
CPH54A - + + + + +
CPH548 - + + + + +
cDNA was syntesized from mRNA isolated from exponentially growing
SCLC cell lines. PCR was performed as described in Materials and methods
using specific oligonucleotides and run on an agarose gel. Bands were
visualized by ultraviolet light +, specific band with correct size; (+), specific
but faint band; -, no band.
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Figure 4 SCLC cell lines were cultured until confluence with change of medium 24 h prior to the experiment Cells were tysed and immunoprecipitated with
1 gg monocbnal antibody directed against MMP-9 (A) (GLC14 not tested) and run on a 7.5% SD-PAGE gel or TIMP-2 (B) and run on a 12.5-20% SDS-PAGE
gradient gel. Antigens were detected by incubating the blots with the corresponding antibodies, followed by incubation with blotinylated rabbit-anti-mouse IgG
and streptavidin conjugated horseradish peroxidase. Bands were visualized by ECL, according to manufacture's instruction. In (C), GLC2 cells were incubated
in the presence (+) or absence (-) of 1 jig ofmonoclonal antibody directed against TIMP-2. Bound antigens were detected as described above. Molecular
weight markers (rainbow markers, Amersham) are indicated on the let Arrowheads indicate the92kda MMP-9 and the28-lDa TIMP-2. Experiments were
performed twice with similar results
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Table 5 In vitro invasion in the presence of EGFR-neutralong mAb528
Addition
Cell line None Ue-P IgG mAb528
MAR24H 100.0+5.1 90.1 ±13.4 114.7±10.1 44.9±3.2
P-value 0.351 0.160 0.003
DMS53 100.0 11.0 88.2+ 11.5 90.7±11.8 41.3+ 17.8
P-value 0.245 0.793 0.002
CPH54A 100.0 9.6 105.5 ± 2.7 100.9 ±4.0 66.0 ± 3.3
P-value 0.373 0.916 0.007
SCLC cell lines were seeded on Transwell fitters coated with 50 pg Matrigel under serum-free condions for
24 h. Invasion was determined by the MTT assay in the presence of the control antibody tre-P, mouse IgG or
the EGFR neutralizing mAb528 (all 3pg mt-1). Invasion was normalized to the invasion in the absence of
antibody. In the EGFR-negative cell lines GLC3, GLC14 and NCIH69, very low levels of invasion was found
(< 2%). Addition of UtrP, mouse IgG and mAb528 did not influence these low values. Experiments were
performed twice with similar results.
cells were unlikely to be attached to the underside of the filters.
The breast cancer cell line MDA-MB-23 1 has a high number of
EGFR and a high degree of in vitro invasion (Fitzpatrick et al.
1984: Long and Rose. 1996). In all experiments. this cell line was
used as a positive control and the invasion was scored as +++. The
invasion of SCLC cell lines was then related to the invasion of
MDA-MB-231. This in vitro invasion was scored from negative 0
to +++i-. No invasion was scored as 0. few cells as +. numerous
cells as ++ and a similar number ofinvading SCLC cells to that of
MDA-MB-231 as +++. The results are summarized in Table 1. The
scoring was performed by two of the authors (LD and NB. the
latter without the knowledge of EGFR status). The filters were
stained and photographed as seen in Figure 1. in which the in vitro
invasion of2 SCLC cell lines and MDA-MB-231 cell line is illus-
trated. Based on these data. we could divide our panel of SCLC
cell lines into two groups: cells with an ability to cross the
Matrigel membrane and cells without this ability. From Table 1. it
can be seen that all the EGFR-positive cell lines had in vitro inva-
sive capability. It is also shown that all the EGFR-negative cell
lines did not traverse the Matrigel membrane. Furthermore. it
appears that the in vitro invasion did not correlate with the growth
characteristics ofthe SCLC cell lines. i.e. cells growing as floating
aggregates vs monolayer cultures.
Quantified in vitro invasion
To quantify in vitro invasion. we selected eight EGFR-positive and
four EGFR-negative SCLC cell lines (Table 2. A). These cell lines
were tested in an invasion assay with a longer incubation time
(24 h). Invasion was performed on Transwell filters under serum-
containing conditions. As illustrated in Table 2 B. the degree of
invasion in EGFR-positive cell lines ranged from 5.0% ± 1.4%
(DMS114) to 16.2% ± 7.8% (DMS92). whereas in the EGFR-
negative SCLC cell lines tested less than 2.3% of the cells
traversed the Matrigel membrane. These results therefore agree
with the results from the in vitro invasion based on light
microscopy.
In vitro invasion with different Matrigel concentrations
To assess whether the inability of the EGFR-negative cell lines to
traverse the Matrigel membrane was due to an impaired migration!
motility capability. we performed the in vitro 'invasion' in the
absence of Matrigel. Furthermore, to evaluate the fidelity of the
Matrigel membrane. we also performed the assay using 100 ig
Matrigel/filter. For these studies. we selected the same EGFR-posi-
tive and -negative SCLC cell lines as above. We found that. in the
examined SCLC cell lines. migration/motility was between 19.3%
and 50.6% in the eight examined EGFR-positive cell lines and
between 22.9% and 28.3% in the four EGFR-negative cell lines
(Table 2 C). This indicates that non-invasive SCLC cell lines did not
have afaulty motility ability. suggesting thatthe EGFR-negative cell
lines had a lower or defective ability to degrade the Matrigel
membrane. Furthermore. we found that the in vitro invasion in
EGFR-positive SCLC cell lines was significantly lower in experi-
ments using 100-jg compared with 50 fig Matrigel/filter (Figure 2
and Table 2 D). These results. as well as the lack ofin vitro invasion
in EGFR-negative cell lines. indicated that the Matrigel membrane
forms a physical barrier. which has to be degraded before cells
appear in the lowercompartment
Proteolytic activity of SCLC cell lines
Our finding that the Matrigel membrane formed a physical barrier
which had to be degraded indicated that SCLC cell lines secreted
proteolytic enzymes enabling the degradation of the Matrigel
membrane. To determine the proteolytic activity ofthe SCLC cell
lines. zymography of conditioned medium was performed. In
Figure 3. the results of a zymogram are shown. It can be seen that
SCLC cell lines express a variety of enzymes able to degrade f-
casein (Figure 3A). In other experiments. all SCLC cell lines were
found to express gelatine-degrading proteases (Figure 3B). To
explore these proteolytic enzymes further, we examined selected
proteases by immunoprecipitation. Western blot analysis and RT-
PCR. In immunoprecipitation studies. we examined MMP-9 and
TIMP-2 (Table 3). A representative blot for MMP-9 is seen in
Figure 4A. showing that all the 20 examined SCLC cell lines
expressed the 92-kDa protein MMP-9. Figure 4B shows a TIMP-2
immunoprecipitation blot. The specificity ofthe TIMP-2 immuno-
precipitation in GLC2 is seen in Figure 4C. Western blot analysis
was used to analyse the presence of MMP-1. MMP-2 and
cathepsin B: these results are shown in Table 3. In Table 4. the
results from RT-PCR using specific oligonucleotides to detect
MMP-2. MMP-3. MMP-9. TIMP-1. TIMP-2 and TIMP-3 are
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summarized. Our results from the zymograms, immunoprecipita-
tion and Western blot analysis and RT-PCR studies indicate that
SCLC cell lines expressed a variety of proteolytic enzymes and
inhibitors. However, a pattern of expression of these molecules
that could distinguish in vitro invasive SCLC cell lines from non-
invasive was not apparent.
In vitro invasion in the presence of EGFR neutralizing
mAb
Our results raised the question ofwhether the EGFR was involved
in the in vitro invasive phenotype of the examined SCLC cell
lines. To address this question, we performed quantified in vitro
invasion in the presence of the EGFR-neutralizing mouse mono-
clonal antibody mAb528 using Transwell filters. As a control,
these experiments were also performed in the presence ofthe irrel-
evant mouse monoclonal antibody tre-P or mouse IgG. For these
experiments, we selected six cell lines: the EGFR-negative SCLC
cell lines GLC3, GLC14 and NCIH69 and the three EGFR-
positive SCLC cell lines MAR24H, DMS53 and CPH54A. For
comparison, the results were normalized to the invasion in the
absence of antibody. We show that in vitro invasion in the three
EGFR-positive cell lines was reduced significantly after mAb528
addition to 44.9% (MAR24H), 41.3% (DMS53) and 66.0%
(CPH54A) (P-values = 0.003, 0.002 and 0.007 respectively).
Experiments performed in the presence of tre-P or mouse IgG did
not influence invasion, indicating that the EGFR was directly
involved in the in vitro invasive phenotype of SCLC cell lines
(Table 5). In the three EGFR-negative SCLC cell lines, no effect
was observed (data not shown).
DISCUSSION
In this study, we have examined a panel of SCLC cell lines for
their ability to traverse a reconstituted Matrigel membrane and
related this in vitro invasion to the EGFR status. Ofthe 21 SCLC
cell lines in our panel, 11 cell lines were characterized as EGFR
positive based on Northern blot analysis, chemical cross-linking
and Scatchard analysis of the binding data and ten cell lines as
EGFR-negative (Damstrup et al, 1992). All cell lines were
analysed in aBoyden chamber assay and the in vitro invasion was
semiquantifiedby comparing the invasion ofSCLC cell lines with
MDA-MB-231 cells. We show that all 11 EGFR-positive SCLC
cell lines were invasive, whereas none of the EGFR-negative cell
lines had the ability to traverse the reconstituted Matrigel
membrane (Table 1). This difference in in vitro invasion was
confirmed in the quantified invasion assay. However, the level of
in vitro invasion was independent of growth characteristics and
EGFRexpression level (Tables 1 and 2). In other cell types, a role
for the EGFR has also been demonstrated, Holting et al, (1995)
have shown that in a follicular thyroid cancer cell line EGF or
transforming growth factor a (TGFa) stimulated invasion over
unstimulated cells (P < 0.02). Similar results were found by
Hamada et al (1995) in rat mammary carcinoma cells, in which
EGF, in a dose-dependent manner, stimulated in vitro invasion.
Thus, our results support the notion that EGFR has a role in the
invasive phenotype.
Examination of the motility/migration of the cell lines showed
that all examined SCLC cell lines in this assay had a similar high
degree of motility, irrespective of EGFR expression. Hence, in
EGFR-negative SCLC cell lines the Matrigel membrane formed a
physical barrier that could not be traversed. whereas EGFR-
positive SCLC cell lines had the ability to degrade the Matrigel
membrane.
The examined SCLC cell lines expressed a variety of proteo-
lytic enzymes, which could degrade the Matrigel membrane.
However, we could not differentiate between in vitro invasive and
non-invasive SCLC cell lines based on the expression pattern of
the examined proteases. Furthermore, in a preliminary study of
four SCLC cell lines in our panel, no difference in protein expres-
sion of uPA, urokinase-type plasminogen activator receptor
(uPAR) or plasminogen activator inhibitor (PAI ) was found
among the two examined EGFR-positive and the two EGFR-nega-
tive cell lines (L Damstrup et al, unpublished observation). Others
have found that growth factors belonging to the EGF-like family
ofligands could stimulate different systems involved in the degra-
dation of basement membrane. Harvey et al (1995) have shown
that EGF was able to stimulate the production of MMP-9 in blas-
tocyst outgrowth. Yoshida et al (1990) have shown that EGF and
TGF-a increased expression of MMP-3 and MMP-7 in a human
gastric carcinoma cell line. Lund et al (1995) have shown that EGF
stimulation of the lung cancer cell line A549 resulted in increased
expression ofuPA. These results suggest that the EGFR. at least to
some extent, can be involved in the invasive phenotype by regu-
lating the production of proteolytic enzymes capable ofdegrading
crucial basement membrane components.
The observation that TIMP-2 was expressed by in vitro invasive
SCLC cell lines raised the question why invasive SCLC cell lines
expressed an inhibitor of a proteolytic enzyme. An explanation
might be that TIMP-2 increases the stability ofthe 72 kDa type IV
collagenase bypreventing autocatalytic activation anddegradation
(Howard et al, 1991; Kleineret al, 1993).
All SCLC cell lines in our panel express one or more of the
ligands that binds to the EGFR (L Damstrup et al, unpublished
observation) and, to address the role of endogenously produced
ligands binding to the EGFR, we examined the in vitro invasion in
the presence of the EGFR-neutralizing mAb528. We showed that
mAb528 significantly reduced the in vitro invasion in three
EGFR-positive cell lines, whereas no alteration in in vitro invasion
was seen after the addition of control mAb or mouse IgG. Our
results suggest that the positive SCLC cell lines produced biologi-
cally active ligands that bound to the EGFR in an autocrine
fashion. Furthermore, our results suggest that this ligand- receptor
binding may influence the production ofproteases involved in the
in vitro invasion.
More direct evidence for an involvement of EGFR in the inva-
sive phenotype has been reported by Lichtner et al (1995). They
examined two clones of the rat mammary tumour 13762NF. One
clone expressed high levels ofEGFR and had a high incidence of
lung metastasis. The other clone expressed low levels of EGFR
and formed few metastases. After stable transfection with EGFR,
the low-EGFR-expressing clone had a higher incidence of meta-
stasis. Xie et al (1995) transfected DU-145, human prostate carci-
noma cells, with full-length EGFR and showed that the transfected
cells had a 1.8-fold increased invasion in human amniotic base-
ment membrane matrix compared with the parental cell line. We
have recently, in two lacZ-transfected SCLC cell lines, found
formation of metastasis in nu/nu-META/Bom mice. In GLC2
metastasis was seen frequently, whereas in DMS456 metastasis
was seen only in a few cases (R0meret al, 1995). Our observation
that only EGFR-positive SCLC cell lines were invasive in the in
vitro system are thus supported bythese in vivodata.
British Journal ofCancer(199)78(5), 631-640 0CancerResearch Campaign 1998In conclusion, we have demonstrated that in our panel of 21
SCLC cell lines in vitro invasion was strongly correlated with the
presence of the EGFR. We also demonstrate that all SCLC cell
lines expressed several enzymes able to degrade components of
the basement membrane. However. an expression pattern among
EGFR-positive or EGFR-negative SCLC cell lines could not be
established. indicating that several regulatory mechanisms are
involved in conferring in vitro invasion in SCLC cell lines.
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